Stock listing

Cytophage Technologies Ltd.

Selected listing: CYTO · NEO · CAD · CA

Cytophage Technologies Ltd. (Cboe Canada: CYTO), Finance. Latest release May 22, 2026: Cytophage Announces Filings Under the BIA.

CYTO:NEOCADCAUpdated October 1, 2026

Ticker: Cboe Canada: CYTO
Asset type: Stock
Sector: Finance
Industry: Financial Conglomerates
Exchange: Cboe Canada
Currency: CAD

About Cytophage Technologies Ltd.

Cytophage Technologies Ltd. (ticker: CYTO) is a public company based in Canada focused on developing innovative solutions in biotechnology. The company aims to advance its proprietary technologies to address significant challenges in healthcare. Cytophage is committed to improving patient outcomes through its research and development efforts.

Latest news from Cytophage Technologies Ltd.

Cytophage Announces Filings Under the BIA

May 22, 2026

Cytophage Announces Resignation of Director

May 1, 2026

Cytophage Announces Departure of Chief Operating Officer

April 14, 2026

Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives

March 6, 2026

Canadian Investment Regulatory Organization Trade Resumption - CYTO

February 19, 2026

All Cytophage Technologies Ltd. news →

Research Cytophage Technologies Ltd.

Cytophage Technologies Ltd. company profile

View the public company page for Cytophage Technologies Ltd. on 6ix.

Cytophage Technologies Ltd. news

Read company news and market updates connected to Cytophage Technologies Ltd..

Cytophage Technologies Ltd. investor events

Find investor webinars, events, and replay context for Cytophage Technologies Ltd..